Dexamethasone protects auditory hair cells against TNFα-initiated apoptosis via activation of PI3K/Akt and NFκB signaling
Dexamethasone protects auditory hair cells against TNFα-initiated apoptosis via activation of PI3K/Akt and NFκB signaling
复制标题
DOI:
10.1016/j.heares.2009.05.003
复制
发表时间:
2009-09-01
期刊:
影响因子:
2.8
通讯作者:
Van De Water, Thomas R.
中科院分区:
文献类型:
--
作者:
Haake, Scott M.;Dinh, Christine T.;Van De Water, Thomas R.
Background: Tumor necrosis factor alpha (TNF alpha) is associated with trauma-induced hearing loss. Local treatment of cochleae of trauma-exposed animals with a glucocorticoid is effective in reducing the level of hearing loss that occurs post-trauma (e.g., electrode insertion trauma-induced hearing loss/dexamethasone treatment).Hypothesis: Dexamethasone (Dex) protects auditory hair cells (AHCs) from trauma-induced loss by activating cellular signal pathways that promote cell survival.Materials and methods: Organ of Corti explants challenged with an ototoxic level of TNF alpha was the trauma model with Dex the otoprotective drug. A series of inhibitors were used in combination with the Dex treatment of TNF alpha-exposed explants to investigate the signal molecules that participate in Dex-mediated otoprotection. The otoprotective capacity of Dex against TNF alpha ototoxicity was determined by hair cell counts obtained from fixed explants stained with FITC-phalloidin labeling with investigators blinded to specimen identity.Results: The general caspase inhibitor Boc-d-fmk prevented TNF alpha-induced AHC death. There was a significant reduction (p < 0.05) in the efficacy of Dex otoprotection against TNF alpha ototoxicity when the following cellular events were blocked: (1) glucocorticoid receptors (Mif); (2) PI3K (LY294002); (3) Akt/PKB (SH-6); and (4) NF kappa B (NF kappa B-I).Conclusion: Dex treatment protects hair cells against TNF alpha apoptosis in vitro by activation of PI3K/Akt and NF kappa B signaling. (C) 2009 Elsevier B.V. All rights reserved.